Glycogen storage diseases represent a metabolic domain within biochemistry characterized by pathogenic deficiencies in specific enzymes regulating glycogenesis and glycogenolysis pathways. The core theoretical mechanism dictates that disruptions in rate-limiting enzymes (e.g., glycogen synthase, phosphorylase) or structural modification enzymes (branching/debranching) lead to distinct phenotypes defined by the accumulation of abnormal glycogen substrates or failure to release free glucose into systemic circulation. Consequently, these disorders manifest as organ-specific pathologies driven by substrate overload in tissues such as the liver and heart, establishing a causal link between enzymatic regulation failures and metabolic homeostasis collapse.
Glycogen storage diseases represent a metabolic domain within biochemistry characterized by pathogenic deficiencies in specific enzymes regulating glycogenesis and glycogenolysis pathways. The core t…